Search company, investor...

Allvivo Vascular

Founded Year



Grant | Alive

Total Raised


Last Raised

$1M | 12 yrs ago

About Allvivo Vascular

Provider of biomimetic surface coatings for cardiovascular devices. The company's initial biomimetic stent coating targets the coronary stent market and is designed to be an alternative to immuno-suppressive and cytotoxic drugs on stents. Its coatings are designed to increase the safety and efficacy of coated stents while eliminating the need to extend antiplatelet therapy beyond one month. [Keyword: DES]

Headquarters Location

20914 Bake Parkway Suite 100

Lake Forest, California, 92630,

United States


Missing: Allvivo Vascular's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Allvivo Vascular's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Allvivo Vascular Patents

Allvivo Vascular has filed 1 patent.

The 3 most popular patent topics include:

  • Antibiotics
  • Dosage forms
  • Drug delivery devices
patents chart

Application Date

Grant Date


Related Topics



Dosage forms, Drug delivery devices, Polymers, Antibiotics, Routes of administration


Application Date


Grant Date


Related Topics

Dosage forms, Drug delivery devices, Polymers, Antibiotics, Routes of administration



Latest Allvivo Vascular News

Medical Device Coating Market size will be USD 19 billion by 2029 : GreyViews

Dec 29, 2022

Major Players Royal DSM, Surmodics, Inc., PPG Industries, Inc., Sono-Tek Corporation, Materion Corporation, Hydromer Inc., Precision Coating Company, Inc., Freudenberg Medical, AST Products, Inc., Biocoat Incorporated, Covalon Technologies Ltd., Harland Medical Systems, Specialty Coating Systems Inc., Medical Surface Inc., Merit Medical Systems, Inc., Medicoat, Allvivo Vascular, Inc. among others Segmentation Analysis The antimicrobial coatings segment is expected to be the fastest-growing segment in 2021. The product segment includes Hydrophilic Coatings, Antimicrobial Coatings, Drug-eluting Coatings, Anti-thrombogenic Coatings, and Others. The antimicrobial coatings segment is expected to witness the highest growth rate during the forecast period. This is explained by their low cost and excellent compatibility with a variety of device materials, including metal, plastic, carbon fibre, composite materials, and stainless steel. The segment will expand as a result of increased implanted device use and rising R&D initiatives. The cardiovascular segment is expected to be the fastest-growing segment in 2021. The application segment includes Neurology, Orthopedics, General Surgery, Cardiovascular, Dentistry, Gynecology, and Others. The cardiovascular segment is expected to witness the highest growth rate during the forecast period. Because more people are getting implants and cardiac pacemakers. The market will expand as a result of the increased demand for coronary stents with drug-eluting coatings. An increase in cardiovascular disease incidence will be brought on by increased usage of these devices, an aging population, poor eating habits, and a sedentary lifestyle. Additionally, during the forecast period, favourable government policies like reimbursement coverage and increased healthcare spending will support the expansion of the cardiovascular segment. Regional Analysis            The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the medical device coating include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia. The North America region witnessed a major share. This is due to both the availability of good healthcare services and the rise in cardiometabolic diseases including Pulmonary Embolism (PE) and Deep Vein Thrombosis. Additionally, it is projected that the need for medical device coating would rise in the next years as a result of the rapidly rising COVID-19 positive cases, the widespread use of cutting-edge surgical techniques, and the growing healthcare infrastructure in the United States. Country Analysis Germany Germany's medical device coating market size was valued at USD 0.15 billion in 2021 and is expected to reach USD 0.23 billion by 2029, at a CAGR of 5.8% from 2022 to 2029. The growing need for these materials in cardiology, general surgery, and neurology equipment is driving the market for medical device coatings. China China’s medical device coating market size was valued at USD 0.24 billion in 2021 and is expected to reach USD 0.44 billion by 2029, at a CAGR of 8% from 2022 to 2029. A potential barrier to the market's growth may be the adverse effects of antimicrobial coatings on human health, however significant technological developments in antimicrobial coating are opening up chances for regional markets for medical coatings. India India's medical device coating market size was valued at USD 0.20 billion in 2021 and is expected to reach USD 0.36 billion by 2029, at a CAGR of 6.5% from 2022 to 2029. An surge in hospital-acquired infections has put more pressure on the healthcare system, which is cause for concern for the industry. The surge in illnesses contracted in hospitals has slightly raised the pressure on the healthcare sector. Antimicrobial coatings help decrease hospital acquired infections thanks to a variety of attributes, including biocompatibility. Covid-19 Impact Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries. Furthermore, the growth of this market is mainly driven due to the Increasing awareness regarding the advancement of medical treatments is also likely to boost the demand for medical coatings. Buy Now Full Report @ Contact Us

Allvivo Vascular Frequently Asked Questions (FAQ)

  • When was Allvivo Vascular founded?

    Allvivo Vascular was founded in 1999.

  • Where is Allvivo Vascular's headquarters?

    Allvivo Vascular's headquarters is located at 20914 Bake Parkway, Lake Forest.

  • What is Allvivo Vascular's latest funding round?

    Allvivo Vascular's latest funding round is Grant.

  • How much did Allvivo Vascular raise?

    Allvivo Vascular raised a total of $3.4M.

  • Who are the investors of Allvivo Vascular?

    Investors of Allvivo Vascular include National Institutes of Health, Eno River Capital and Redmont Venture Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.